Duovent® UDV Inhalation Solution

Manufacturer:
Boehringer Ingelheim (Canada) Ltd.

Generic Name:
ipratropium bromide and fenoterol hydrobromide

Product Illustration Form:
nebulizer

Route:
oral inhalation


Why is it prescribed?

Duovent® UDV Inhalation Solution contains ipratropium bromide and fenoterol hydrobromide.

Duovent® UDV inhalation solution is used to relieve wheezing, coughing, chest tightness and/or shortness of breath in COPD (bronchitis and emphysema). It is also used to relieve these symptoms in an acute asthma episode.

 

Side Effects

Duovent® UDV Inhalation Solution contains ipratropium bromide and fenoterol hydrobromide.

Poor control of symptoms with Duovent® can often be attributed to improper use of the nebulizer. Be sure to follow the directions given to you by your pharmacist, and read the patient instructions that are provided with each product. If you are not responding to your usual dose or your symptoms get worse contact your doctor. Never increase the dose or frequency of the dose without being instructed to do so.
Do not take any other respiratory medications without your doctors instructions.
Accidently getting Duovent® mist in your eyes can temporarily blur vision, worsen glaucoma and cause eye pain. Do not let any of the nebulized mist get into your eyes. Be sure the mask fits properly or use a nebulizer with a mouthpiece. People who have glaucoma sometimes use swimming goggles to protect their eyes.
Drug Interactions: Be sure to tell your doctor and pharmacist about any prescription or over-the- counter medications you are taking in order to avoid any potential drug interactions.
The following drugs and drug classes have been known to interact with Duovent ®

  • MAO (monoamine oxidase) inhibitors (e.g. phenelzine, tranylcypromine)
  • tricyclic antidepressants (e.g. amitriptyline)
  • some beta-blockers (e.g. propranolol)
  • xanthines (e.g. theophylline)

Use is not recommended in the following situations:
  • allergy to any component of the preparation
  • cardiac arrhythmia associated with tachycardia (irregular heart beat associated with rapid heart rate) Caution is recommended in the following situations:
    • hyperthyroidism
    • diabetes
    • cardiovascular disorders (heart disease) cardiac arrhythmia (irregular heart beat)
    • heart disease
    • glaucoma (narrow angle)
    • enlarged prostate
    • blockage of the urinary bladder

        Use in pregnancy: Consult your doctor or pharmacist if you suspect you are pregnant. Use while breast-feeding: Consult your doctor or pharmacist before you begin breast-feeding.

         

        Patient Information

        The Duovent® Unit Dose Vials (UDV) are for inhalation only via nebulizer. Each vial contains a combination of 2 bronchodilators (ipratropium and fenoterol). Your doctor, pharmacist or health care provider will instruct you on the proper use and care of the nebulizer. Make sure you understand exactly how to use it before proceeding. Once the vial has been opened it is important that you use it as soon as possible. If you have been instructed to use a portion of the contents, any solution left over must be thrown out. Store Duovent® Unit Dose Vials at room temperature (between 15 and 30 degrees centigrade)and protect from light and heat.

         

        Directions for Use

        The usual dose for adults and children over 12 years is 4 mL of solution every 6 hours if necessary.

         

        Lung Diseases Treated with this Drug

        ipratropium bromide

        • allergic rhinitis
        • asthma
        • bronchitis
        • bronchospasm associated with COPD
        • chronic bronchitis (COPD)
        • COPD
        • emphysema (COPD)
        • hay fever
        • perennial rhinitis
        • rhinitis
        • runny nose
        • seasonal rhinitis
        fenoterol hydrobromide
        • asthma
        • bronchitis
        • bronchospasm associated with COPD
        • chronic bronchitis (COPD)
        • COPD
        • emphysema (COPD)

         

        Need More Information?

        For more information contact your physician, pharmacist, other health care professional or for general questions call your local lung association.